首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1671878

藥物釋放型支架市場按產品類型、應用、最終用戶和地區分類

Drug Eluting Stents Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球藥物釋放型支架市場規模估計為 84.9 億美元，預計到 2032 年將達到 152.2 億美元，2025 年至 2032 年的複合年成長率為 8.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	84.9 億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	8.70％	2032 年價值預測	152.2億美元

數字。 2025 年藥物釋放型支架市場佔有率（按地區分類）

由於心血管疾病發病率不斷上升以及世界老年人口不斷增加，老年人易患冠狀動脈疾病和動脈阻塞，全球藥物釋放型支架市場在過去幾年中經歷了顯著成長。與裸金屬支架相比，藥物釋放型支架因其優點（包括血管再阻塞率較低）越來越受到醫師的青睞。此外，支架設計和支架表面藥物塗層的技術進步也改善了患者的臨床治療效果。然而，與裸金屬支架相比，藥物釋放型支架的成本較高，這是市場成長的一大障礙。

市場動態：

全球藥物釋放型支架市場的發展受到老年人口不斷成長、心血管疾病負擔不斷增加以及藥物釋放型支架相對於裸金屬支架的優勢（例如血管再阻塞率較低）的推動。然而，與裸金屬支架相比，藥物釋放型支架的成本較高，可能會阻礙市場成長。支架技術和藥物塗層的各種發展預計將為市場參與者提供豐厚的機會。例如，生物可吸收藥物釋放型支架（作用後可在體內溶解）很可能會得到更廣泛的應用。同樣，開發增強藥物分子結合的支架表面可以幫助縮短藥物釋放型時間並降低治療成本。

本研究的主要特點

本報告對全球藥物釋放型支架市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、性能和策略等參數，介紹了全球藥物釋放型支架市場的主要企業概況。

本研究涉及的主要企業包括雅培實驗室、波士頓科學公司、美敦力、泰爾茂株式會社、B. Braun Melsungen AG、CR Bard Inc.、庫克醫療公司、Biotronik SE &Co.KG、微創科學公司、聖猶達醫療公司（現為雅培的一部分）、強生公司、心血管系統公司、戈爾朝日、Inspire Zire、Hire Zire、Mpire ASAHI INTECC CO., LTD.、Tire。

本報告提供的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

本研究報告研究了全球藥物釋放型支架市場，並將其提供給該行業的各個相關人員，例如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。

相關人員可以透過分析全球藥物釋放型支架市場所使用的各種策略矩陣來促進決策。

Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
B. Braun Melsungen AG
CR Bard Inc.
Cook Medical Inc.
Biotronik SE & Co. KG
MicroPort Scientific Corporation
Jude Medical（now part of Abbott）
Johnson & Johnson
Cardiovascular Systems Inc.
Gore Medical
InspireMD
Asahi Intecc Co., Ltd.
Z-Medica

第 9 章分析師建議

第10章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI566

Global Drug Eluting Stents Market is estimated to be valued at US$ 8.49 Bn in 2025 and is expected to reach US$ 15.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	US$ 8.49 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.70%	2032 Value Projection:	US$ 15.22 Bn

Figure. Drug Eluting Stents Market Share (%), By Region 2025

The global drug eluting stents market has witnessed significant growth in the past few years owing to the rising prevalence of cardiovascular diseases and increasing geriatric population worldwide who are more prone to coronary heart diseases and artery blockages. Drug eluting stents are increasingly being preferred by physicians over bare metal stents due to advantages such as lower rates of restenosis. Moreover, technological advancements in design of stents and drugs coated on stent surfaces have improved clinical outcomes for patients. However, high costs of drug eluting stents compared to bare metal stents remain a major challenge for market growth.

Market Dynamics:

The global drug eluting stents market is driven by the rising geriatric population, growing burden of cardiovascular diseases, and advantages offered by drug eluting stents over bare metal stents such as lower restenosis rates. However, the high costs of drug eluting stents compared to bare metal stents can hamper the market growth. Various developments in stent technology and drug coatings are expected to present lucrative opportunities for market players. For example, bioabsorbable drug eluting stents that dissolve in the body after performing their action could witness increasing adoption. Likewise, development of stent surfaces that enhance binding of drug molecules could help reduce drug elution times and costs of treatment.

Key Features of the Study:

This report provides in-depth analysis of the global drug eluting stents market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug eluting stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard Inc., Cook Medical Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, St. Jude Medical (now part of Abbott), Johnson & Johnson, Cardiovascular Systems Inc., Gore Medical, InspireMD, Asahi Intecc Co., Ltd., and Z-Medica

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug eluting stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting stents market

Market Segmentation

By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Polymer-based Coatings
- Non-biodegradable Polymers
- Biodegradable Polymers
- Polymer free Coatings
- Micro porous Surface
- Micro structured Surface
- Slotted Tubular Surface
- Nanoporous Surface
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Coronary Artery Disease
- Peripheral Artery Disease
- Others
By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Cardiac Catheterization Labs
- Ambulatory Surgical Centers
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic
- Terumo Corporation
- B. Braun Melsungen AG
- C. R. Bard Inc.
- Cook Medical Inc.
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- Jude Medical (now part of Abbott)
- Johnson & Johnson
- Cardiovascular Systems Inc.
- Gore Medical
- InspireMD
- Asahi Intecc Co., Ltd.
- Z-Medica

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Eluting Stents Market, By Product Type
- Global Drug Eluting Stents Market, By Application
- Global Drug Eluting Stents Market, By End User
- Global Drug Eluting Stents Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Eluting Stents Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Polymer-based Coatings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-biodegradable Polymers
Biodegradable Polymers
Polymer free Coatings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Micro porous Surface
Micro structured Surface
Slotted Tubular Surface
Nanoporous Surface

5. Global Drug Eluting Stents Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Coronary Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peripheral Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Drug Eluting Stents Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Catheterization Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Drug Eluting Stents Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
C. R. Bard Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jude Medical (now part of Abbott)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiovascular Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gore Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
InspireMD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asahi Intecc Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Z-Medica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies